MétaCan
Menu
Back to cohort
Record W2588711318 · doi:10.1093/neuonc/now212.178

CSIG-17. COMPENSATORY ACTIVATION OF STAT3 TRIGGERED BY EGFR INHIBITION: A MECHANISM OF RESISTANCE IN GBM BRAIN TUMOR INITIATING CELLS

2016· article· en· W2588711318 on OpenAlexaff
Katharine V. Jensen, H. Artee Luchman, Samuel Weiss

Bibliographic record

VenueNeuro-Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicCytokine Signaling Pathways and Interactions
Canadian institutionsOntario Brain InstituteUniversity of Calgary
Fundersnot available
KeywordsAfatinibCancer researchSTAT3EGFR inhibitorsSignal transductionIn vivoBiologyErlotinibEpidermal growth factor receptorCancerMedicineCell biologyGenetics

Abstract

fetched live from OpenAlex

Despite advances in delineating the mutations and aberrant signaling pathways underlying glioblastoma multiforme (GBM), the prognosis for GBM patients remains dismal. New therapeutic options are desperately needed in order to make this devastating disease manageable. In cancer cells, when one survival signaling pathway is inhibited, network redundancy leads to compensatory mechanisms that activate other survival/proliferation pathways. This mechanism may explain the poor clinical translation of EGFR inhibitors in GBM to date. JAK2/STAT3 signaling is important for tumor cell survival, growth, and invasion and becomes trans-activated upon EGFR inhibition. Given that both EGFR and JAK2/STAT3 are crucial signaling hubs in GBM, if targeted concurrently, this may provide the survival advantage that monotherapies have failed to offer. To test this hypothesis, we examined the actions of the JAK2 inhibitor pacritinib in combination with the EGFR inhibitor afatinib on GBM brain tumor initiating cells (BTICs). STAT3 activation triggered by EGFR inhibition was confirmed in multiple BTIC lines. Protein and mRNA levels of STAT3 and IL6 were found to increase, highlighting a possible mechanism of resistance to EGFR inhibition. We demonstrated that concurrent inhibition of STAT3 and EGFR exhibited striking responses, with extensive synergy and dramatic decreases in BTIC viability and sphere-forming capacity. Western blotting assays showed that the increased phospho-STAT3 observed with EGFR inhibition was abolished with combined treatment. Consistent with in vitro results, EGFR inhibition with afatinib induced an increase in phospho-STAT3 in vivo, in BTIC orthotopic xenografts. This increase was abolished with the combination of afatinib and pacritinib. These data suggest that, in GBM, EGFR inhibition remains of high therapeutic relevance, when combined with inhibition of other pro-oncogenic pathways. Our ongoing studies are aimed at further understanding the mechanism by which STAT3 is activated upon EGFR inhibition and the translational potential of inhibiting these two pathways in combination.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.016
Threshold uncertainty score0.444

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.293
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicCytokine Signaling Pathways and InteractionsFrench-language works237,207